These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 1855215

  • 1. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
    Watson PH, Pon RT, Shiu RP.
    Cancer Res; 1991 Aug 01; 51(15):3996-4000. PubMed ID: 1855215
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Jun 01; 62(11):3126-31. PubMed ID: 12036924
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H.
    Neurosurgery; 1997 Oct 01; 41(4):908-15. PubMed ID: 9316053
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the proliferative effect of transforming growth factor-alpha by c-myc antisense DNA in human ovarian cancer cells.
    Park HY.
    Biochem Mol Biol Int; 1997 Dec 01; 43(5):1015-22. PubMed ID: 9415810
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide.
    Watson PH, Pon RT, Shiu RP.
    Exp Cell Res; 1992 Oct 01; 202(2):391-7. PubMed ID: 1397092
    [Abstract] [Full Text] [Related]

  • 6. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C, Connell Y, Neckers L.
    Mol Pharmacol; 1995 Oct 01; 48(4):738-46. PubMed ID: 7476902
    [Abstract] [Full Text] [Related]

  • 7. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
    Saijo Y, Uchiyama B, Abe T, Satoh K, Nukiwa T.
    Jpn J Cancer Res; 1997 Jan 01; 88(1):26-33. PubMed ID: 9045892
    [Abstract] [Full Text] [Related]

  • 8. Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines.
    Melkoumian ZK, Martirosyan AR, Strobl JS.
    Int J Cancer; 2002 Nov 01; 102(1):60-9. PubMed ID: 12353235
    [Abstract] [Full Text] [Related]

  • 9. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
    Akie K, Dosaka-Akita H, Murakami A, Kawakami Y.
    Antisense Nucleic Acid Drug Dev; 2000 Aug 01; 10(4):243-9. PubMed ID: 10984118
    [Abstract] [Full Text] [Related]

  • 10. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
    Kang Y, Cortina R, Perry RR.
    J Natl Cancer Inst; 1996 Mar 06; 88(5):279-84. PubMed ID: 8614006
    [Abstract] [Full Text] [Related]

  • 11. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW, Nguyen D, Anderson S, Allegra CA.
    Anticancer Res; 1997 Mar 06; 17(6D):4407-13. PubMed ID: 9494542
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 14. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
    Williams SA, Gillan ER, Knoppel E, Buzby JS, Suen Y, Cairo MS.
    Ann Oncol; 1997 Apr 03; 8 Suppl 1():25-30. PubMed ID: 9187425
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. c-Myc overexpression and endocrine resistance in breast cancer.
    McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL.
    J Steroid Biochem Mol Biol; 2006 Dec 03; 102(1-5):147-55. PubMed ID: 17052904
    [Abstract] [Full Text] [Related]

  • 18. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
    Tsai LC, Hung MW, Yuan CC, Chao PL, Jiang SY, Chang GG, Chang TC.
    Anticancer Res; 1997 Dec 03; 17(6D):4557-62. PubMed ID: 9494568
    [Abstract] [Full Text] [Related]

  • 19. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S, Skorski T, Cucco C, Nieborowska-Skorska M, Chiu CY, Lloyd D, Chen JK, Koziolkiewicz M, Calabretta B.
    Nucleic Acids Res; 1996 Apr 15; 24(8):1508-14. PubMed ID: 8628685
    [Abstract] [Full Text] [Related]

  • 20. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu.
    Roh H, Pippin J, Boswell C, Drebin JA.
    J Surg Res; 1998 Jun 15; 77(1):85-90. PubMed ID: 9698539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.